| 1 |
35152275 | Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p/TrkB axis. | 2022 Jun |
4 |
| 2 |
33711972 | Sensitizing the cytotoxic action of Docetaxel induced by Pentoxifylline in a PC3 prostate cancer cell line. | 2021 Mar 12 |
4 |
| 3 |
34190439 | Developmentally regulated GTP-binding protein 2 levels in prostate cancer cell lines impact docetaxel-induced apoptosis. | 2021 Jul |
1 |
| 4 |
30993586 | Midkine silencing enhances the anti-prostate cancer stem cell activity of the flavone apigenin: cooperation on signaling pathways regulated by ERK, p38, PTEN, PARP, and NF-κB. | 2020 Apr |
1 |
| 5 |
31834633 | The stem cell inhibitor salinomycin decreases colony formation potential and tumor-initiating population in docetaxel-sensitive and docetaxel-resistant prostate cancer cells. | 2020 Feb |
2 |
| 6 |
30171201 | Acetyl-11-keto-β-boswellic acid suppresses docetaxel-resistant prostate cancer cells in vitro and in vivo by blocking Akt and Stat3 signaling, thus suppressing chemoresistant stem cell-like properties. | 2019 May |
1 |
| 7 |
29314097 | Effect of FAK inhibitor VS-6063 (defactinib) on docetaxel efficacy in prostate cancer. | 2018 Mar |
1 |
| 8 |
30100995 | RNA sequencing reveals upregulation of a transcriptomic program associated with stemness in metastatic prostate cancer cells selected for taxane resistance. | 2018 Jul 13 |
2 |
| 9 |
30519360 | The Combination of Omega-3 Stearidonic Acid and Docetaxel Enhances Cell Death over Docetaxel Alone in Human Prostate Cancer Cells. | 2018 |
1 |
| 10 |
28212536 | Targeting the stress oncoprotein LEDGF/p75 to sensitize chemoresistant prostate cancer cells to taxanes. | 2017 Apr 11 |
1 |
| 11 |
28533751 | Docetaxel-Loaded Nanoparticles Assembled from β-Cyclodextrin/Calixarene Giant Surfactants: Physicochemical Properties and Cytotoxic Effect in Prostate Cancer and Glioblastoma Cells. | 2017 |
1 |
| 12 |
28758908 | Targeting Apoptotic Activity Against Prostate Cancer Stem Cells. | 2017 Jul 29 |
1 |
| 13 |
29187435 | Evaluating Metformin as a Potential Chemosensitizing Agent when Combined with Docetaxel Chemotherapy in Castration-resistant Prostate Cancer Cells. | 2017 Dec |
2 |
| 14 |
26404131 | Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells. | 2016 Feb |
2 |
| 15 |
27542265 | Metabolic shift toward oxidative phosphorylation in docetaxel resistant prostate cancer cells. | 2016 Sep 20 |
2 |
| 16 |
25708950 | Paradoxical effects of the autophagy inhibitor 3-methyladenine on docetaxel-induced toxicity in PC-3 and LNCaP prostate cancer cells. | 2015 Jul |
4 |
| 17 |
23728939 | Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy. | 2014 Feb |
3 |
| 18 |
24194567 | Phosphoproteomic profiling identifies focal adhesion kinase as a mediator of docetaxel resistance in castrate-resistant prostate cancer. | 2014 Jan |
2 |
| 19 |
25104727 | The role of testicular nuclear receptor 4 in chemo-resistance of docetaxel in castration-resistant prostate cancer. | 2014 Oct |
1 |
| 20 |
25333266 | Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition. | 2014 Nov 30 |
3 |
| 21 |
22996738 | Functional p53 determines docetaxel sensitivity in prostate cancer cells. | 2013 Mar |
3 |
| 22 |
23192362 | Gefitinib inhibits the cross-talk between mesenchymal stem cells and prostate cancer cells leading to tumor cell proliferation and inhibition of docetaxel activity. | 2013 May |
1 |
| 23 |
24179545 | β4-integrin-mediated cytotoxic activity of AexU in human prostate cancer PC3 cells. | 2013 Nov |
1 |
| 24 |
24405548 | [2-deoxyglucose enhances chemosensitivity of androgen-independent prostate cancer cells to docetaxel]. | 2013 Oct 29 |
5 |
| 25 |
22811914 | Combination effects of docetaxel and Doxorubicin in hormone-refractory prostate cancer cells. | 2012 |
2 |
| 26 |
22952424 | CXCR4 inhibition with AMD3100 sensitizes prostate cancer to docetaxel chemotherapy. | 2012 Aug |
1 |
| 27 |
21035484 | Targeting the cancer initiating cell: the Achilles' heel of cancer. | 2011 |
2 |
| 28 |
21549092 | Combined effect of sodium selenite and docetaxel on PC3 metastatic prostate cancer cell line. | 2011 May 20 |
2 |
| 29 |
21645351 | Synergistic effects of oncolytic reovirus and docetaxel chemotherapy in prostate cancer. | 2011 Jun 6 |
2 |
| 30 |
21711774 | Novel docetaxel-loaded nanoparticles based on poly(lactide-co-caprolactone) and poly(lactide-co-glycolide-co-caprolactone) for prostate cancer treatment: formulation, characterization, and cytotoxicity studies. | 2011 Mar 28 |
1 |
| 31 |
19912186 | Suppressed tumour growth and enhanced chemosensitivity by RNA interference targeting Aurora-A in the PC3 human prostate cancer model. | 2010 Jul |
1 |
| 32 |
20551061 | The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy. | 2010 Jul 1 |
1 |
| 33 |
20729074 | Bevacizumab/docetaxel association is more efficient than docetaxel alone in reducing breast and prostate cancer cell growth: a new paradigm for understanding the therapeutic effect of combined treatment. | 2010 Nov |
1 |
| 34 |
20816710 | In vitro anticancer activity of docetaxel-loaded micelles based on poly(ethylene oxide)-poly(epsilon-caprolactone) block copolymers: Do nanocarrier properties have a role? | 2010 Dec 1 |
2 |
| 35 |
19103299 | Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells. | 2009 Feb |
1 |
| 36 |
18189232 | 2-chloroadenosine modulates PAR-1 and IL-23 expression and enhances docetaxel effects on PC3 cells. | 2008 Mar 1 |
3 |
| 37 |
18594829 | Docetaxel and bortezomib downregulate Bcl-2 and sensitize PC-3-Bcl-2 expressing prostate cancer cells to irradiation. | 2008 Oct |
3 |
| 38 |
19050703 | Dexamethasone potentiates the antiangiogenic activity of docetaxel in castration-resistant prostate cancer. | 2008 Dec 16 |
1 |
| 39 |
14991863 | Antitumor activity of irofulven monotherapy and in combination with mitoxantrone or docetaxel against human prostate cancer models. | 2004 Apr 1 |
1 |
| 40 |
12222966 | Survival of docetaxel-resistant prostate cancer cells in vitro depends on phenotype alterations and continuity of drug exposure. | 2002 Jul |
1 |
| 41 |
12439335 | Synergistic and antagonistic combinations of drugs in human prostate cancer cell lines in vitro. | 2002 Nov |
1 |
| 42 |
11182366 | Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3. | 2001 Feb |
6 |